MOESM1 of Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
Takahiro Sawada
Hideo Tsubata
Naoko Hashimoto
Michinori Takabe
Taishi Miyata
Kosuke Aoki
Soichiro Yamashita
Shogo Oishi
Tsuyoshi Osue
Kiminobu Yokoi
Yasue Tsukishiro
Tetsuari Onishi
Akira Shimane
Yasuyo Taniguchi
Yoshinori Yasaka
Takeshi Ohara
Hiroya Kawai
Mitsuhiro Yokoyama
10.6084/m9.figshare.c.3606221_D2.v1
https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Effects_of_6-month_eicosapentaenoic_acid_treatment_on_postprandial_hyperglycemia_hyperlipidemia_insulin_secretion_ability_and_concomitant_endothelial_dysfunction_among_newly-diagnosed_impaired_glucose_metabolism_patients_with_coronary_artery_dis/4348037
Additional file 1: Table S1. Multiple regression analysis for predicting incremental glucose peak improvement.
2016-08-26 05:00:00
Eicosapentaenoic acid
Impaired glucose metabolism
Postprandial hyperglycemia
Postprandial insulin secretion
Postprandial hypertriglyceridemia
Endothelial dysfunction